FOX RUN MANAGEMENT, L.L.C.
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1533457
GREENWICH, CT
Position in RYTM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$391,278
+$137,087 QoQ
Shares Held
4,499
+78.7% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $29,784,980 across 59 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NAMS |
NewAmsterdam Pharma Co N.V.
|
59,477 | $2,015,675 | |
| 2 | RPRX |
Royalty Pharma plc
|
24,094 | $1,350,950 | |
| 3 | IMVT |
Immunovant, Inc.
|
34,827 | $1,341,884 | |
| 4 | ASND |
Ascendis Pharma A/S
|
4,726 | $1,260,518 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
28,315 | $1,104,568 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
38,178 | $1,001,027 | |
| 7 | EXEL |
Exelixis, Inc.
|
18,255 | $993,254 | |
| 8 | EYPT |
EyePoint, Inc.
|
58,528 | $836,950 |
All Filings in RYTM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $391,278 | 4,499 | Shares | Sole | 2026-05-12 | |
| 2025-09-30 | $254,191 | 2,517 | Shares | Sole | 2025-11-12 | |
| 2025-03-31 | $1,015,540 | 19,172 | Shares | Sole | 2025-05-13 | |
| 2023-09-30 | $393,989 | 17,186 | Shares | Sole | 2023-11-07 | |
| 2023-03-31 | $677,028 | 37,950 | Shares | Sole | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||